Mina Kim
Also at ACELYRIN, Inc.
About
Mina Kim serves as the Chief Executive Officer of ACELYRIN, INC., a late-stage clinical biopharma company, and brings extensive experience from previous leadership roles in legal and corporate strategy across diverse industries.
Born in 1974, she has built a reputation for her strategic vision and legal acumen. Prior to her appointment as CEO, she held senior positions at companies such as Zymergen, Inc., Atara Biotherapeutics, Inc., Sunrun Inc., and BBAM, LLC, where she honed her expertise in corporate development and legal oversight.
Since her promotion to CEO on May 09, 2024, she has been instrumental in refocusing the company’s pipeline strategy and ensuring a strong financial foundation, which includes managing significant resources to advance their strategic initiatives.
Her transition from a legal officer to the chief executive role highlights her versatility and commitment to driving growth and innovation within the organization, positioning the company for future success in the competitive biopharma landscape.